|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
|
US6262115B1
(en)
*
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
|
HUP0104420A2
(en)
*
|
1998-12-02 |
2002-08-28 |
Darwin Discovery Ltd |
Therapeutic composition containing a new form of tramadol and its use
|
|
AU3064800A
(en)
*
|
1999-01-21 |
2000-08-07 |
Darwin Discovery Limited |
The therapeutic use of r-warfarin as anticoagulant
|
|
US20030170181A1
(en)
*
|
1999-04-06 |
2003-09-11 |
Midha Kamal K. |
Method for preventing abuse of methylphenidate
|
|
PE20010623A1
(es)
*
|
1999-10-05 |
2001-07-07 |
Gruenenthal Chemie |
Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
|
|
EP1313460A2
(en)
*
|
1999-11-09 |
2003-05-28 |
Darwin Discovery Limited |
Therapeutic use and formulation of (-)-tramadol
|
|
DE10004926A1
(de)
|
2000-02-04 |
2001-08-09 |
Gruenenthal Gmbh |
Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
|
|
AU3582101A
(en)
|
2000-03-01 |
2001-09-12 |
Euro-Celtique S.A. |
The treatment of functional gastrointestinal disorders
|
|
US20010036959A1
(en)
*
|
2000-04-03 |
2001-11-01 |
Gabel Rolf Dieter |
Carvedilol-hydrophilic solutions
|
|
CA2423558A1
(en)
*
|
2000-10-03 |
2002-04-11 |
Penwest Pharmaceuticals Company |
Delivery system for multi-pharmaceutical active materials at various release rates
|
|
WO2002065834A2
(en)
*
|
2000-10-24 |
2002-08-29 |
Smithkline Beecham Corporation |
Novel formulations of carvedilol
|
|
US6562871B1
(en)
*
|
2000-11-06 |
2003-05-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Dry granulation of pharmaceutical formulation comprising mexiletine
|
|
DE10108122A1
(de)
*
|
2001-02-21 |
2002-10-02 |
Gruenenthal Gmbh |
Arzneimittel auf Basis von Tramadol
|
|
IN191028B
(https=)
*
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
WO2003048113A1
(en)
|
2001-11-30 |
2003-06-12 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
|
US8128957B1
(en)
|
2002-02-21 |
2012-03-06 |
Valeant International (Barbados) Srl |
Modified release compositions of at least one form of tramadol
|
|
US20050182056A9
(en)
*
|
2002-02-21 |
2005-08-18 |
Seth Pawan |
Modified release formulations of at least one form of tramadol
|
|
EP1562552A1
(en)
*
|
2002-11-08 |
2005-08-17 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
WO2004056336A2
(en)
*
|
2002-12-20 |
2004-07-08 |
Ranbaxy Laboratories Limited |
Controlled release, multiple unit drug delivery systems
|
|
WO2004071501A1
(en)
*
|
2003-02-10 |
2004-08-26 |
Shire Biochem Inc. |
Enantiomeric amphetamine compositions for the treatment of adhd
|
|
WO2004103361A2
(en)
*
|
2003-05-20 |
2004-12-02 |
Ranbaxy Laboratories Limited |
A pharmaceutical dosage form of citalopram
|
|
US8263126B2
(en)
*
|
2003-06-06 |
2012-09-11 |
Ethypharm |
Orally-dispersible multilayer tablet
|
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
|
CA2547137A1
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
EP1686967A4
(en)
*
|
2003-11-25 |
2012-08-08 |
Smithkline Beecham Cork Ltd |
CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
|
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
AU2005290829B2
(en)
*
|
2004-10-01 |
2011-06-09 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Solid pharmaceutical preparation
|
|
WO2007048219A2
(en)
|
2005-09-09 |
2007-05-03 |
Labopharm Inc. |
Sustained drug release composition
|
|
EP1976488A4
(en)
*
|
2006-01-12 |
2010-02-10 |
Wockhardt Ltd |
ALFUZOSIN PROLONGED RELEASE PREPARATIONS
|
|
JP5120652B2
(ja)
*
|
2006-03-30 |
2013-01-16 |
日本臓器製薬株式会社 |
固形医薬製剤
|
|
CN101674728A
(zh)
|
2007-02-12 |
2010-03-17 |
Dmi生物科学公司 |
降低曲马多的副作用
|
|
CA2677690C
(en)
*
|
2007-02-12 |
2012-05-15 |
James V. Winkler |
Treatment of comorbid premature ejaculation and erectile dysfunction
|
|
CN103977003A
(zh)
|
2007-04-02 |
2014-08-13 |
帕金森氏病研究院 |
用于降低治疗的副作用的方法和组合物
|
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|